Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy-Reference-Cited by-同舟云学术

Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy

Published:2017-06-01 Issue:3 Volume:102 Page:493-501
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Harada S¹,Zhou Y²,Duncan S³,Armstead AR³,Coshatt GM³,Dillon C⁴,Brott BC⁵,Willig J⁶,Alsip JA³,Hillegass WB⁷,Limdi NA⁴

Affiliation:

1. Department of Pathology; University of Alabama at Birmingham; Birmingham Alabama USA

2. Department of Pathology; University of Oklahoma Health Sciences Center; Norman Oklahoma USA

3. University of Alabama at Birmingham Health System; Birmingham Alabama USA

4. Department of Neurology; University of Alabama at Birmingham; Birmingham Alabama USA

5. Department of Medicine, Division of Cardiovascular Diseases; University of Alabama at Birmingham; Birmingham Alabama USA

6. Department of Medicine, Division of Infectious Diseases; University of Alabama at Birmingham; Birmingham Alabama USA

7. Heart South Cardiovascular Group; Birmingham AL

Funder

UAB's Health Service Foundations' General Endowment Fund

Hugh Kaul Personalized Medicine Institute

National Heart Lung and Blood Institute

National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference56 articles.

1. Prioritizing genomic applications for action by level of evidence: a horizon-scanning method;Dotson;Clin. Pharmacol. Ther.,2014

2. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC);Caudle;Genet. Med.,2016

3. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network;Relling;Clin. Pharmacol. Ther.,2011

4. The FDA announces new drug labeling for pharmacogenetic testing: is personalized medicine becoming a reality?;Vladutiu;Mol. Genet. Metab.,2008

5. Clinical implementation of genetic testing in medicine: a US regulatory science perspective;Lesko;Br. J. Clin. Pharmacol.,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping Review;Therapeutic Drug Monitoring;2024-09-11

2. Evaluation of Potential Racial Disparities in CYP2C19 ‐Guided P2Y ₁₂ Inhibitor Prescribing After Percutaneous Coronary Intervention;Clinical Pharmacology & Therapeutics;2022-11-19

3. How to implement a pharmacogenetics service at your institution;JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY;2022-09-12

4. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing;Annual Review of Genomics and Human Genetics;2022-08-31

5. Strategies and settings of clinical pharmacogenetic implementation: a scoping review of pharmacogenetics programs;Pharmacogenomics;2021-04